Palvella Therapeutics (PVLA) Gross Profit (2013 - 2014)
Palvella Therapeutics' (PVLA) quarterly Gross Profit came in at $2.1 million in Q3 2014, up 17415208.33% year-on-year from N/an in Q3 2013, and up 17415208.33% on a QoQ basis from -$12.0 in Q3 2013.
Palvella Therapeutics (PVLA) Gross Profit (2013 - 2014) Analysis & Trends
Palvella Therapeutics (PVLA) has 2 years of Gross Profit data on file, last reported at $2.1 million in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 2.09 Mn |
| Sep 30, 2014 | 2.09 Mn |
| Sep 30, 2013 | -12.00 |
| Sep 30, 2013 | -12.00 |